These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 9171234

  • 1. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
    [Abstract] [Full Text] [Related]

  • 2. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M, Gilbert S, Rosenthal W.
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W.
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [Abstract] [Full Text] [Related]

  • 4. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI, Cho HY, Park HW, Ha IS, Choi Y.
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [Abstract] [Full Text] [Related]

  • 6. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
    Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
    [Abstract] [Full Text] [Related]

  • 7. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM, Nickols HH, Limbird LE.
    J Biol Chem; 2003 Sep 12; 278(37):35678-86. PubMed ID: 12824183
    [Abstract] [Full Text] [Related]

  • 8. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ.
    Am J Physiol Renal Physiol; 2009 Dec 12; 297(6):F1518-25. PubMed ID: 19812297
    [Abstract] [Full Text] [Related]

  • 9. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.
    Yokoyama K, Yamauchi A, Izumi M, Itoh T, Ando A, Imai E, Kamada T, Ueda N.
    J Am Soc Nephrol; 1996 Mar 12; 7(3):410-4. PubMed ID: 8704106
    [Abstract] [Full Text] [Related]

  • 10. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
    Ranadive SA, Ersoy B, Favre H, Cheung CC, Rosenthal SM, Miller WL, Vaisse C.
    Clin Endocrinol (Oxf); 2009 Sep 12; 71(3):388-93. PubMed ID: 19170711
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.
    Makita N, Sato T, Yajima-Shoji Y, Sato J, Manaka K, Eda-Hashimoto M, Ootaki M, Matsumoto N, Nangaku M, Iiri T.
    J Biol Chem; 2016 Oct 21; 291(43):22460-22471. PubMed ID: 27601473
    [Abstract] [Full Text] [Related]

  • 12. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV, Deen PM.
    Ned Tijdschr Geneeskd; 2000 Dec 09; 144(50):2402-4. PubMed ID: 11145096
    [Abstract] [Full Text] [Related]

  • 13. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T, Yun J, Wenkert D, Wess J.
    EMBO J; 1996 Mar 15; 15(6):1283-91. PubMed ID: 8635461
    [Abstract] [Full Text] [Related]

  • 14. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
    Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T, Inada M.
    J Clin Invest; 1995 Oct 15; 96(4):2043-50. PubMed ID: 7560098
    [Abstract] [Full Text] [Related]

  • 15. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
    Schwieger I, Lautz K, Krause E, Rosenthal W, Wiesner B, Hermosilla R.
    Mol Pharmacol; 2008 Mar 15; 73(3):697-708. PubMed ID: 18048502
    [Abstract] [Full Text] [Related]

  • 16. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
    Armstrong SP, Seeber RM, Ayoub MA, Feldman BJ, Pfleger KD.
    PLoS One; 2013 Mar 15; 8(6):e65885. PubMed ID: 23762448
    [Abstract] [Full Text] [Related]

  • 17. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
    Inaba S, Hatakeyama H, Taniguchi N, Miyamori I.
    J Clin Endocrinol Metab; 2001 Jan 15; 86(1):381-5. PubMed ID: 11232028
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W, Seibold A, Antaramian A, Gilbert S, Birnbaumer M, Bichet DG, Arthus MF, Lonergan M.
    Cell Mol Biol (Noisy-le-grand); 1994 May 15; 40(3):429-36. PubMed ID: 7920187
    [Abstract] [Full Text] [Related]

  • 20. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
    Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T.
    J Biol Chem; 2012 Jan 13; 287(3):2099-106. PubMed ID: 22144672
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.